These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 2329421

  • 1. Prospective evaluation of aluminum loading from formula in infants with uremia.
    Salusky IB, Coburn JW, Nelson P, Goodman WG.
    J Pediatr; 1990 May; 116(5):726-9. PubMed ID: 2329421
    [Abstract] [Full Text] [Related]

  • 2. Infant formula as a cause of aluminium toxicity in neonatal uraemia.
    Freundlich M, Zilleruelo G, Abitbol C, Strauss J, Faugere MC, Malluche HH.
    Lancet; 1985 Sep 07; 2(8454):527-9. PubMed ID: 2863545
    [Abstract] [Full Text] [Related]

  • 3. Aluminum concentrations in serum, dialysate, urine and bone among patients undergoing continuous ambulatory peritoneal dialysis (CAPD).
    Joffe P, Olsen F, Heaf JG, Gammelgaard B, Pödenphant J.
    Clin Nephrol; 1989 Sep 07; 32(3):133-8. PubMed ID: 2791364
    [Abstract] [Full Text] [Related]

  • 4. Aluminum accumulation during treatment with aluminum hydroxide and dialysis in children and young adults with chronic renal disease.
    Salusky IB, Foley J, Nelson P, Goodman WG.
    N Engl J Med; 1991 Feb 21; 324(8):527-31. PubMed ID: 1992306
    [Abstract] [Full Text] [Related]

  • 5. The use of deferoxamine in the management of aluminum accumulation in bone in patients with renal failure.
    Malluche HH, Smith AJ, Abreo K, Faugere MC.
    N Engl J Med; 1984 Jul 19; 311(3):140-4. PubMed ID: 6377067
    [Abstract] [Full Text] [Related]

  • 6. [Elimination of aluminum via continuous ambulatory peritoneal dialysis].
    Passlick J, Wilhelm M, Busch T, Grabensee B, Ohnesorge FK.
    Dtsch Med Wochenschr; 1989 Jan 06; 114(1):9-13. PubMed ID: 2910699
    [Abstract] [Full Text] [Related]

  • 7. Elevated bone aluminum content in dialysis patients without osteomalacia.
    McCarthy JT, Kurtz SB, McCall JT.
    Mayo Clin Proc; 1985 May 06; 60(5):315-20. PubMed ID: 3990380
    [Abstract] [Full Text] [Related]

  • 8. Aluminium in bone from patients with renal failure.
    Parsons V, Davies C, Goode C, Ogg C, Siddiqui J.
    Br Med J; 1971 Oct 30; 4(5782):273-5. PubMed ID: 5123910
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics of desferrioxamine and of its iron and aluminum chelates in patients on peritoneal dialysis.
    Allain P, Chaleil D, Mauras Y, Varin MC, Ang KS, Cam G, Simon P.
    Clin Chim Acta; 1988 Apr 29; 173(3):313-6. PubMed ID: 3383431
    [Abstract] [Full Text] [Related]

  • 10. Scalp hair as an indicator of aluminium exposure: comparison to bone and plasma.
    Wilhelm M, Passlick J, Busch T, Szydlik M, Ohnesorge FK.
    Hum Toxicol; 1989 Jan 29; 8(1):5-9. PubMed ID: 2785480
    [Abstract] [Full Text] [Related]

  • 11. Aluminum accumulation in children on chronic dialysis: predictive value of serum aluminum levels and desferrioxamine infusion test.
    Roodhooft AM, van de Vyver FL, D'Haese PC, van Acker KJ, Visser WJ, de Broe ME.
    Clin Nephrol; 1987 Sep 29; 28(3):125-9. PubMed ID: 3665205
    [Abstract] [Full Text] [Related]

  • 12. Aluminum intoxication from aluminum-containing phosphate binders in children with azotemia not undergoing dialysis.
    Andreoli SP, Bergstein JM, Sherrard DJ.
    N Engl J Med; 1984 Apr 26; 310(17):1079-84. PubMed ID: 6708989
    [Abstract] [Full Text] [Related]

  • 13. Diagnosis of aluminum-related bone disease and treatment of aluminum toxicity with deferoxamine.
    Coburn JW, Norris KC.
    Semin Nephrol; 1986 Dec 26; 6(4 Suppl 1):12-21. PubMed ID: 3299588
    [Abstract] [Full Text] [Related]

  • 14. Intraperitoneal deferoxamine therapy for aluminum intoxication in a child undergoing continuous ambulatory peritoneal dialysis.
    Andreoli SP, Dunn D, DeMyer W, Sherrard DJ, Bergstein JM.
    J Pediatr; 1985 Nov 26; 107(5):760-3. PubMed ID: 3932629
    [No Abstract] [Full Text] [Related]

  • 15. Application of an erythrocyte aluminum assay in the diagnosis of aluminum-associated microcytic anemia in patients undergoing dialysis and response to deferoxamine therapy.
    Abreo K, Brown ST, Sella M, Trapp G.
    J Lab Clin Med; 1989 Jan 26; 113(1):50-7. PubMed ID: 2909650
    [Abstract] [Full Text] [Related]

  • 16. Treatment of aluminum toxicity in infantile uremia with deferoxamine.
    Freundlich M, Zilleruelo G, Faugere MC, Abitbol C, Strauss J, Malluche HH.
    J Pediatr; 1986 Jul 26; 109(1):140-3. PubMed ID: 3723235
    [No Abstract] [Full Text] [Related]

  • 17. Do serum aluminum levels reflect underlying skeletal aluminum accumulation and bone histology before or after chelation by deferoxamine?
    Hodsman AB, Hood SA, Brown P, Cordy PE.
    J Lab Clin Med; 1985 Dec 26; 106(6):674-81. PubMed ID: 4067379
    [Abstract] [Full Text] [Related]

  • 18. Reversibility of parathyroid gland suppression in CAPD patients with low i-PTH levels.
    Montenegro J, Saracho R, González O, Moina I, Martínez I.
    Clin Nephrol; 1997 Dec 26; 48(6):359-63. PubMed ID: 9438094
    [Abstract] [Full Text] [Related]

  • 19. Prevention and treatment of aluminum intoxication in chronic renal failure.
    Simon P, Allain P, Ang KS, Cam G, Mauras Y.
    Adv Nephrol Necker Hosp; 1985 Dec 26; 14():439-78. PubMed ID: 3919543
    [No Abstract] [Full Text] [Related]

  • 20. [Detecting and evaluating hyperaluminemia in 3 dialysis centers].
    Balabán D, Simícková J, Kubátko J, Syrovátka P.
    Cas Lek Cesk; 1989 Dec 15; 128(51):1611-4. PubMed ID: 2631999
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.